Montelucast sodium tablets 4mg, pulminar-4

Kopran Limited offers a wide range of products which includes montelucast sodium tablets 4mg, pulminair-4. It belongs to respiratory category. Antiasthmatic pulminair 5 montelukast is a potent, orally administered for asthematic condition active compound that significantly improves parameters of asthmatic inflammation. Based on biochemical and pharmacological bioassays, it binds with high affinity and selectivity to the CysLT1 receptor. Montelukast potently inhibits physiologic actions of LTC4, LTD4and LTE4 at the CysLT1 receptor without any agonist activity. Montelukast acts as a mast cell stabilizer. Packing: Box of 10 x 1 x10's. Indications: Pluminair are indicated used for: asthma as add- on therapy in those patients with mild to moderate persistent asthma who are inadequately controlled on inhaled corticosteroids and in whom “as needed” â-agonists provide inadequate clinical control of asthma, symptomatic relief of seasonal allergic rhinitis, prophylaxis of asthma in which the predominant component is exercise - induced bronchoconstriction.